CALC News | Roxom Stocks

Mkt Cap

$7.4M

Volume

10.58K

Next Earnings

November 11th

Chart Financials Earnings News About Insider Filings

Hypertension Clinical Trial Pipeline Accelerates as 100+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsightOver 100 pharmaceutical companies are actively developing 110+ pipeline hypertension drugs, with approximately 40+ in late-stage development. Key players include Gossamer Bio, Alnylam Therapeutics, Roche, GSK, and others pursuing novel mechanisms like RNA interference and CRAC channel inhibitors. Recent developments include FDA acceptance of lorundrostat's NDA, initiation of zilebesiran's Phase III cardiovascular outcomes trial, and multiple clinical advances in emerging therapies targeting uncontrolled and resistant hypertension.GlobeNewswire Inc. · Sep 16, 2026

Is Alcon (ALC) Stock Outpacing Its Medical Peers This Year?Here is how Alcon (ALC) and CalciMedica Inc. (CALC) have performed compared to their sector so far this year.Zacks Investment Research · May 23, 2024

CalciMedica And 2 Other Penny Stocks Insiders Are BuyingThe Dow Jones index closed lower by around 400 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. CalciMedica The Trade: CalciMedica, Inc. (NASDAQ: CALC) Chief Business Officer Eric W Roberts acquired a total of 4,000 shares an average price of $3.90. To acquire these shares, it cost around $15,600. What’s Happening: On March 28, CalciMedica posted a fourth-quarter loss of 23 cents ...Benzinga · Apr 3, 2024

Top 4 Health Care Stocks That May Crash This QuarterAs of Feb. 2, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70, according to Benzinga Pro. Here’s the latest list of major overbought players in this sector. PepGen Inc. (NASDAQ: PEPG) On Jan. 8, PepGen said First Patient was dosed in CONNECT1-EDO51 Phase 2 clinical trial of PGN-EDO51 for duchenne muscular dystrophy patients amenable to Exon 51 skipping. The company’s stock ...Benzinga · Feb 2, 2024

Gannett And 3 Other Stocks Under $4 Insiders Are BuyingThe Dow Jones closed higher by around 35 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. Local Bounti The Trade: Local Bounti Corporation (NYSE: LOCL) Chief Technology Officer Travis M Joyner acquired a total of 4,220 shares an average price of $2.37. To acquire these shares, it cost around $10,000. The company’s CFO also bought 2,000 shares. What’s Happening: Deutsche Bank recently downgraded Local Bounti from Buy to Hold and lowered ...Benzinga · Nov 7, 2023

Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday's Mid-Day SessionGainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical gliblastoma results with its lead candidate, TTX-MC138. FaZe Holdings Inc. (NASDAQ: FAZE) gained 46.9% to $0.2247 after falling over 4% on Friday. Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares climbed 23.5% to $0.1472 after gaining 16% on Friday. The company recently announced the sale of its assets relating to AVTX-801 (D-galactose), AVTX-802 (D-mannose) and AVTX-803 (L-fucose) on Sept. 12. Biophytis S.A. (NASDAQ: BPTS) shares gained 22.3% to $1.1250 after the company and Skyepharma announced the signature of a partnership agreement for the production of regulatory batches of Sarconeos (BIO101) for severe forms of Covid-19. Cano Health, Inc. (NYSE: CANO) rose 20.5% to $0.2727. Sharps Technology, Inc. (NASDAQ: STSS) surged 18.2% to $0.6703. CalciMedica, Inc. (NASDAQ: CALC) climbed 16.3% to $3.0699. TradeUP Acquisition Corp. (NASDAQ: UPTD) gained 14% to $14.50 So-Young International Inc. (NASDAQ: SY) gained 13.5% to $1.2263. Shattuck Labs, Inc. (NASDAQ: STTK) rose 13.3% to $1.71. Pasithea Therapeutics Corp. (NASDAQ: KTTA) gained 13.1% to $0.4998. Enthusiast Gaming Holdings Inc. (NASDAQ: EGLX) gained 12.7% to $0.3367. InnSuites Hospitality Trust (NYSE: IHT) surged 12.5% to $1.4399. Canopy Growth Corporation (NASDAQ: CGC) rose 12.5% to $0.9422. ESS Tech, Inc. (NYSE: GWH) shares climbed 10.1% to $1.53. Honeywell International Inc (NASDAQ: HON) entered into a strategic collaboration with ESS Tech to advance technology development and market adoption of iron flow battery (IFB) energy storage systems. Solo Brands, Inc. (NYSE: DTC) gained 10% to $4.9605. ...Benzinga · Sep 25, 2023

CalciMedica Announces First Patient Enrolled in International Expansion of CARPO Trial of Auxora™ in Acute Pancreatitis (AP)CARPO top-line data expected in 1H2024GlobeNewswire Inc. · Aug 9, 2023

Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionGainers Tivic Health Systems, Inc. (NASDAQ: TIVC) shares jumped 105% to $0.2050 after the company signed a distribution agreement with Cardinal Health. Black Diamond Therapeutics, Inc. (NASDAQ: BDTX) surged 76.3% to $3.2450 after the company announced initial dose escalation data demonstrated anti-tumor activity of BDTX-1535 in non-small cell lung cancer patients across multiple EGFR mutation families. Centogene N.V. (NASDAQ: CNTG) rose 49% to $1.1675 after the company and Lifera formed a Saudi Arabian joint venture. Under the terms of the collaboration, the company will receive a $30 million mandatory convertible loan from Lifera. CalciMedica, Inc. (NASDAQ: CALC) climbed 37% to $4.43. Cara Therapeutics, Inc. (NASDAQ: CARA) gained 22.1% to $3.9547. Cara Therapeutics was granted U.S. Patent #11684674: Oral formulations of kappa opioid receptor agonists. AC Immune SA (NASDAQ: ACIU) rose 19.2% to $2.36 after the company received FDA fast track designation for anti-amyloid-beta active immunotherapy, ACI-24.060 for Alzheimer's disease. American Equity Investment Life Holding Company (NYSE: AEL) shares gained 17.6% to $53.02 after the company announced it has received a $55 per share acquisition proposal from Brookfield Reinsurance. American Rebel Holdings, Inc. (NASDAQ: AREB) jumped 16.6% to $5.47. Biodexa Pharmaceuticals Plc (NASDAQ: BDRX) rose 16.6% to $0.0729. IronNet, Inc. (NYSE: IRNT) gained 14.8% to $0.2067 after dropping 13% on Monday. Astrotech Corporation (NASDAQ: ASTC) gained 13.5% to $12.95. Astrotech 13D filing showed BML Investment Partners, L.P. increased stake in the company to 13%. Aterian, Inc. (NASDAQ: ATER) rose 13% to $0.4099. Enovix Corporation (NASDAQ: ENVX) gained 12.1% to $14.71 after the company announced it received a purchase order to produce battery cells for the U.S. Army. WeWork Inc. (NYSE: WE) rose 11.1% to $0.2601. Moolec Science SA (NASDAQ: MLEC) gained 10.7% to $4.1817. Edgewise Therapeutics, Inc. (NASDAQ: EWTX) rose 9.9% to $7.54 as the company released 12-month topline results from the ARCH study, an open-label, single-center study assessing EDG-5506 in adults with Becker Muscular Dystrophy (BMD). NextPlay Technologies, Inc. (NASDAQ: NXTP) surged ...Benzinga · Jun 27, 2023

CALCCalciMedica, Inc. Common Stock

CALC

Pay with—

Start Trading

Available Balance0.00

Your PositionYou don't own any CALC yet.

Related Tickers

Earnings

Mkt Cap

$7.1M

Volume

10.58K

Next Earnings

November 11th